Atea Pharmaceuticals
AVIR
#7428
Rank
S$0.39 B
Marketcap
$4.65
Share price
1.74%
Change (1 day)
17.70%
Change (1 year)

Atea Pharmaceuticals (AVIR) - Cash on Hand

Cash on Hand as of June 2024 : S$0.66 Billion

According to Atea Pharmaceuticals's latest financial reports the company has S$0.66 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Atea Pharmaceuticals - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.76 B-11.93%
2022-12-31S$0.86 B-16.1%
2021-12-31S$1.03 B-8.12%
2020-12-31S$1.12 B3751.17%
2019-12-31S$29.2 M-38.03%
2018-12-31S$47.12 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.38 B-42.97%๐Ÿ‡บ๐Ÿ‡ธ USA